心臓移植を待っている患者の心血管前置換 - 臨床的ニーズに対応する (PREHAB HTx研究)
Jennifer L Reed1,2,3, Heather E Tulloch1,4, Heather Ross5
1University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
CJC open
|September 2, 2025
まとめ
心臓移植の候補者の機能能力の改善に 期待されています しかし,採用と加入の課題は,代替プログラム設計とリストアップ後の早期の介入を探求することを必要とします.
科学分野:
- 心臓病科
- 移植医学
- リハビリテーション科学
背景:
- 心臓移植の候補者は しばしば機能能力の低下を経験します
- 重度の手術の前に 患者の治療結果を改善することを目的としています
- 心臓移植を受けた患者に対する 予備リハビリテーションの影響を評価することは 極めて重要です
研究 の 目的:
- 心臓移植を待っている成人における機能能力の通常治療 (UC) と対比する12週間の予備治療 (PREHAB) プログラム.
- 心臓呼吸器の健康,弱さ,身体活動,精神的健康,認知機能,生活の質,食事などの二次的アウトカムを評価する.
主な方法:
- 多中心のランダム化制御試験の設計が採用された.
- 参加者はPREHABグループかUCグループにランダムに分けられました.
- PREHABプログラムには 高強度インターバルトレーニング ストレス管理 栄養教育が含まれていました
主要な成果:
- COVID-19 パンデミックを含む様々な障壁により,限定的な募集 (17 件の検診,4 件のランダム化) が行われました.
- PREHABは6分の歩行距離 (343mから465m) の改善の可能性を示した.
- 予備的なデータは,ピーク酸素吸収と生活の質の改善を示唆しています.
結論:
- 心臓移植の候補者の募集と再就活の完了は大きな課題です.
- 将来の研究では 代替のリハビリテーション戦略と早期の介入のタイミングを 調べるべきです
- この集団における予防療法の有効性を最適化するには,参加障壁を取り除くことが不可欠です.
関連する概念動画
01:29Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
27
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
01:20Exercise and Cardiovascular Response
1.1K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27